651
Views
8
CrossRef citations to date
0
Altmetric
Clinical Studies

The Effect of Strict Volume Control on Cognitive Functions in Chronic Hemodialysis Patients

, , , , , , & show all
Pages 641-646 | Received 06 Mar 2009, Accepted 21 Jun 2009, Published online: 09 Oct 2009

REFERENCES

  • Raine AEG, Margreiter R, Brunner FP. EDTA registry report. Nephrol Dial Transplant. 1992;7:7–35.
  • Hegstrom RM, Murray JS, Pendras JP, Burnell JM, Scribner BH. Hemodialysis in the treatment of chronic uremia. ASAIO Trans. 1961;7:136–152.
  • Gunal AI, Duman S, Ozkahya M, Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001;37:588–593.
  • Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291–297.
  • Ozkahya M, Ok E, Cirit M, Regression of left ventricular hypertrophy in hemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 1998;13:1489–1493.
  • Kayikcioglu M, Tumuklu M, Ozkahya M, The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant. 2009;24:956–962.
  • Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004;52:1863–1869.
  • Madan P, Kalra OP, Agarwal S, Tandon OP. Cognitive impairment in chronic kidney disease. Nephrol Dial Transplant. 2007;22:440–444.
  • Goodin DS. Event-related (endogenous) potentials. In Aminoff MJ ( ed.). Electrodiagnosis in clinical neurology. New York: Churchill Livingstone;1992:1215–1218.
  • Tennyson TE, Brown WS, Vaziri ND, Jennison JH. Event-related potential changes during hemodialysis. Int J Artif Organs. 1985;8:269–276.
  • Weisenborn K, Scholz M, Hinrichs H, Wiltfang J, Schmidt FW, Kunkel H. Neurophysiological assessment of early hepatic encephalopathy. Electroencephalogr Clin Neurophysiol. 1990;75:289–295.
  • Ruzicka E, Tesar V, Jelinkova E, Mmerta M, Nevsimalova S, Kucerova O. Event-related potentials in evaluation of metabolic encephalopathies. Schweiz Arch Neurol Psychiatr. 1993;144:378–384.
  • Hart RP, Penderson JA, Czerwinski AW, Adams RL. Chronic renal failure, dialysis and neuropsycological function. J Neuropsych. 1983;4:301–312.
  • Kutlay S, Nergizoglu G, Duman N, Atli T, Keven K, Erturk S. Recognition of neurocognitive dysfunction in chronic hemodialysis patients. Ren Fail. 2002;23:781–787.
  • Elsayed E, Weiner DE. In the literature: Cognitive impairment in hemodialysis patients. Am J Kidney Dis. 2007;49:183–185.
  • Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation. 1977;55:613–618.
  • Bremer BA, Wert KM, Durica AL. Neurophysiological, physical, and psychosocial functioning of individuals with end-stage renal disease. Ann Behav Med. 1997;30:41–49.
  • Tilki HE, Akpolat T, Tunali G, Kara A, Onar MK. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients. Upsala J Med Sci. 2004;109:43–48.
  • Pereira AA, Weir DE, Scott T, Sarnak MJ. Cognitive function in dialysis patients. Am J Kidney Dis. 2005;45:448–462.
  • Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalance, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis. 1997;30:41–49.
  • Gilli P, De Bastiani P. Cognitive function and regular dialysis treatment. Clin Nephrol. 1982;19:188–192.
  • Marsh JT, Brown WS, Wolcott DL, Landswerk J, Nissenson AR. Electrophysiological indices of CNS function in hemodialysis and CAPD. Kidney Int. 1986;30:957–963.
  • Wolcott DL, Wellisch DK, Marsh JT, Schaeffer J, Landsverk J, Nissenson AR. Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients. Am J Kidney Dis. 1988;12:275–284.
  • Wolcott DL, Marsh JT, LaRue A, Carr CR, Nissenson AR. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis. 1989;14:478–485.
  • Grimm G, Stockenhuber F, Schneeweiss B, Madl C, Zeitlhofer J, Schneider B. Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int. 1990;38:480–486.
  • Marsh JT, Brown WS, Wolcott D, rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int. 1991;39:155–163.
  • Gunal AI, Karaca I, Aygen B, Yavuzkir M, Dogukan A, Celiker H. Strict fluid volume control and left ventricular hypertrophy in hypertensive patients on chronic haemodialysis: A cross-sectional study. J Int Med Res. 2004;32:70–77.
  • Gunal AI, Kirciman E, Guler M, Yavuzkir M, Celiker H. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?. Ren Fail. 2004;26:405–409.
  • Parfrey PS, Harnett JD, Griffiths SM, The clinical course of left ventricular hypertrophy in dialysis patients. Nephron. 1990;55:114–120.
  • Jassal SV, Devins GM, Chan CT, Bozanovic R, Rourke S. Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: A longitudinal pilot study. Kidney Int. 2006;70:956–962.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.